Skip to main content
Premium Trial:

Request an Annual Quote

Provista Receives CAP Accreditation for CLIA Lab

NEW YORK (GenomeWeb) – Provista Diagnostics said today that its Scottsdale Ariz.-based CLIA-certified laboratory has received accreditation from the College of American Pathologists.

Provista is a molecular diagnostics firm focused on blood-based proteomic tests for disease including breast and ovarian cancer. Additionally, the company offers diagnostic development services to outside firms through its CLIA facility.

"For development of our own proprietary diagnostics, as well as our work developing companion diagnostics for other companies, CAP accreditation signifies additional assurance that our lab operates under the highest quality standards to generate highly accurate and reliable results." Provista President and CEO David Reese said in a statement.

The CAP Laboratory Accreditation Program involves inspections of clinical lab records and quality control procedures and assessments of a lab's staff qualifications, equipment, facilities, safety program, and overall management.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.